Search Results 631-640 of 18317 for Hepatitis b

1. Cancer Physicians - Medical Professionals - Mayo Clinic

   Vijay Shah, M.D.. Rochester, MN. Area of Focus: Liver transplant, Cirrhosis, Portal hypertension, Liver cancer, Alcoholic hepatitis, Hepatic encephalopathy ...

2. Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR-expressing B-cell Hematologic Malignancies - Mayo Clinic

   ... B-cell Hematologic Malignancies. Print details. Share; Facebook ... Patients with active hepatitis B or hepatitis C infections are excluded from the study.

3. A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens - Mayo Clinic

   Known to be seropositive for hepatitis B (defined by a positive test for hepatitis B surface antigen [HBsAg]). Participants with resolved infection ...

4. Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma - Mayo Clinic

   ... hepatitis B (HepB), or hepatitis C (HepC) positive; Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic ...

5. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies (MorningSun) - Mayo Clinic

   - Positive test results for chronic hepatitis B infection (HBV), acute or chronic hepatitis C virus (HCV) infection, or known or suspected HIV infection - ...

6. A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease - Mayo Clinic

   ... hepatitis B or hepatitis C at screening. History of acute/chronic hepatitis B or C and/or carriers of hepatitis B (seropositive for hepatitis B surface ...

7. Safety and Efficacy of IMM 124-E for Patients with Severe Alcoholic Hepatitis - Mayo Clinic

   ... hepatitis (SAH). Aim: To perform a phase 2a "proof of concept" placebo-controlled, dose-ranging study of Imm 124-E (hyperimmune bovine colostrum enriched ...

8. A Study of Donated Alloantigen Reactive Regulatory T Cells for Reducing or Discontinuing Immune System Suppression in Liver Transplant Patients - Mayo Clinic

   For subjects with hepatitis B, detectible hepatitis B virus (HBV) DNA; History of malignancy within 5 years of enrollment. History of adequately treated in ...

9. Gastroenterology and Hepatology - Doctors - Mayo Clinic

   Transplant Hepatologist. Phoenix, AZ. Areas of focus: Hepatitis C, Hepatitis B, Portal hypertension, Hepatocellular carcinoma, Hepatic encephalopathy ...

10. Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas - Mayo Clinic

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas ... Active hepatitis B; Ongoing ≥ Grade 2 ...